Ligand Pharmaceuticals | LGND - 普通股股本

金融业

USD

USD 1.56B

现金及等价物

USD 174.93M

USD 11.9M

USD 832.27M

USD 37.45M

USD 451M

USD 158.89M

USD 150.32M

68

EPS每股收益

USD 2.02

股本和储备

USD 1.02B

USD 155.28M

债务利息支出

USD 910K

USD 3.87M

USD 445.49M

USD 3.59B

USD 117.27M

USD 8.29M

USD 158.89M

普通股股本

USD 19.66M

60.65

USD 141.14M

USD 59.66M

销售和管理费用

USD 28.45M

USD 9.13M

贸易债权人

USD 3.24M

应收帐款人

USD 58.1M

	普通股股本	更改		日
Agenus	USD 266K		30K	2025-03
Amgen	USD 539M		1000K	2025-12
Anika Therapeutics	USD 143K		1000	2025-03
Arrowhead Research	USD 135.7M		2.44M	2025-09
Baxter International	USD 514.28M		168.72M	2025-12
Bristol-Myers Squibb	USD 2.04B		1.74B	2025-09
Eli Lilly	USD 946.83M		354.23M	2025-06
Enanta Pharmaceuticals	USD 212K		1000	2023-12
Enviri Corporation	USD 81.45M		797K	2025-12
Gilead Sciences	USD 1.24B		1000K	2025-12
GlaxoSmithKline	GBP 4.08B		49.43M	2025-12
Glaxosmithkline	GBP 4.03B		2.68B	2025-09
Heron Therapeutics	USD 188.31M		4.99M	2025-12
Insmed	USD 214.26M		1.67M	2025-12
Intrexon	USD 0		0	2024-06
Ionis Pharmaceuticals	USD 161.97M		836K	2025-12
Karyopharm Therapeutics	USD 13K		0	2024-09
Ligand Pharmaceuticals	USD 19.66M		19.64M	2025-09
MacroGenics	USD 63.26M		62.63M	2025-09
Merck	USD 2.49B		15.79M	2025-09
Pacira	USD 41.12M		1.85M	2025-12
Pfizer	USD 5.69B		1000K	2025-09
Rigel Pharmaceuticals	USD 17K		158K	2024-06
Veracyte	USD 79.05M		377K	2025-12